Interventional Pain Management
Interventional Pain Management
Somatic Blocks of
6 the Head and Neck
SERDAR ERDINE, GABOR B. RACZ, AND CARL E. NOE
BLOCK AND Hakanson in 1981,8 and periorly by the inferior C
NEUROLYSIS OF percutaneous balloon surface of the temporal A
TRIGEMINAL compression by Mullan lobe of the brain, and T
and Lichtor in 1978 and posteriorly by the brain I
GANGLION O
published in 1983.9 stem. The ganglion is
AND N
shaped like a crescent
BRANCHES moon. The convex side is S
A aimed an- terolaterally. It
H N Approaches to the
is bounded medially by the
I A trigeminal ganglion by
internal carotid artery and
S T various methods aim to
trochlear and optic nerves.
T O relieve the pain
The posterior border of
O M transmitted through the
R the ganglion includes the
Y trigeminal nerve. In the
Y dura of Meckel’s cave and
past, trigeminal ganglion
The ganglion lies within cere- brospinal fluid
block has been extensively
Trigeminal neuralgia was the cranium in an area (CSF). Anteriorly, the
used in the treatment of
treated for the first time called Meckel’s cave or ganglion gives off three
trigeminal neuralgia or tic
by alco- hol injection into Meckel’s cavity, close to the branches intracranially:
douloureux. With the
the nerve by Pitres in apex of the pe- trous part ophthalmic, maxillary, and
introduction of
1902.1 He was followed of the temporal bone mandibular.
thermogan- gliolysis, the
by other authors who gave (Figure 6-1A). Medially, Sensation of the oral
trigeminal ganglion
this technique a great deal the trigeminal ganglion is mucosa, anterior and
block is rarely used,
of publicity. By 1905, bounded by the cavernous middle cra- nial fossa,
except for intraoperative
Schlosser2 had reported 68 sinus, su- tooth pulp, surrounding
or postoperative pain. In
cases of severe trigeminal gingiva, and periodontal
addition
neuralgia successfully membrane is innervated
treated by alco- hol nerve by the trigeminal nerve. 77
block. According to Proprio- ceptive
Cushing,3 the information from the
percutaneous muscles of mastication
transforamen ovale and extraoccular muscles
approach to the trigeminal also terminates in the
(gasserian) ganglion using trigeminal gan- glion. The
absolute alcohol was first trigeminal ganglion is
described by Hartel in named after a Viennese
1912.4 anatomist, Johann
In the early 1930s, Laurentius Gasser (Figure
Kirschner5 began to 6-1B). The two medial
use radiofre- (ophthalmic and maxillary)
quency neurolysis. Using are sensory, whereas the
diathermy, it produced lateral most mandibular
high- current lesions of the branch is partly motor.
trigeminal ganglion for The trigeminal ganglion is
relief of trigeminal somatotropically located.
neuralgia, being the first The oph- thalmic branch
report in medical lit- is located dorsally, the
erature to use maxillary branch is
radiofrequency for the intermediate, and the
treatment of chronic mandibular branch is
intractable pain. located ven- trally. These
Putnam and nerves and their branches
Hamptom,6 who provide the cutane- ous
reported 18 cases of and dermatomal
trigeminal neuralgia and innervation of the head
four cases of carcinoma and face as shown in
of the mouth, Figure 6-2.
recommended x-ray Trigeminal ganglion
control during the links with the autonomic
procedure, using 0.5 mil nervous system via the
of 5% phenol, and were ciliary, sphenopalatine,
the first to publish the use otic and submaxil- lary
of phenol as a neurolytic ganglia, and
agent for the treatment of communicates with the
this condition. oculomotor, facial, and
In the evolution of the glossopharyngeal nerves.10
treatment, radiofrequency
(RF) lesioning for this
ganglion was described I
by Sweet and Wepsic in N
1965,7 retrogasserian D
glycerol injection by I
Somatic Blocks 78
Supratrochlear nerve Meckel’s cavity (cisterna trigemina)
Somatic Blocks 79
Supraorbital nerve
Ophthalmic nerve
Maxillary Trigeminal ganglion
nerve
Infraorbital
nerve
Auriculotemporal
nerve
Mandibular
nerve
B Dura
Mental nerve
A
FIGURE 6–1
(A) The figure shows the location of the trigeminal ganglion in the middle cranial fossa and the course of its three branches: (1) oph-
thalmic, (2) maxillary, and (3) mandibular. (B) The relationship of the trigeminal ganglion in Meckel’s cavity. CSF, cerebrospinal
fluid.
EQUIPMENT
DRUGS
Trigeminal Block
Block
■ 25-gauge needle (for skin infiltration)
■ 1% lidocaine for infiltration
■ 5-ml syringe (for local anesthetic solution)
■ 0.25% bupivacaine or 0.2% ropivacaine
■ 22-gauge, B-bevel, 8- to 10-cm needle (for injec-
■ Methylprednisolone, optional
tion of local anesthetic for a block)
Balloon Compression
Radiofrequency Lesioning
■ 1% lidocaine for infiltration
■ RF thermocoagulation (RFTC) lesion generator
■ Iohexol
and cables
■ 25-gauge needle (for skin infiltration)
Neurolytic Block
■ 5-ml syringe (for local anesthetic solution)
■ 16-gauge intravenous catheter (for introducing the ■ Alcohol 97%–1-ml vial or
RF needle) ■ Phenol in saline or glycerin 6%–1 ml or
■ RF needles, 10 cm in length; 2-mm or 5-mm RF ■ Phenol in iohexol 6 to 10%–1 ml
tip (depending on the branch to be lesioned) ■ Glycerol 40 to 50%–1 ml
Supraorbital
nerve
Supratrochlear
nerve
Lacrimal
nerve Auriculotemporal
nerve
Infraorbital Zygomaticotemporal
nerve nerve FIGURE 6–2
This drawing illustrates the innervation of the skin and
Nasociliary
the face by the peripheral branches of the trigeminal
nerve
nerve.
Infraorbital
nerve Zygomaticofacial
nerve
Buccal nerve
Mental nerve
TRIGEMINAL GANGLION BLOCK PROCEDURE (3) needle should be directed toward the pupil when seen
from the front of the face (Figure 6-4A). Cannula insertion
Preparation of Patient
should be performed following the bisector (45°C) of the
Comfort should be provided to the patient during percuta- sagittal plane, which passes through the pupil and the
neous procedures. The patient should be alert enough frontal-mentonian plane.
to respond to the testing, for example, with electrical
stimulation. Generally, intravenous fentanyl (average dose Position of Patient
0.1–0.16 mg), midazolam (average dose 3.0–5.5 mg), and
methohexital (average dose 51.4 mg) are used. In a study The patient is supine on the table with the head in an ex-
comparing several regimens it was concluded that high-dose tended position. The C-arm is placed at the head of the
fentanyl and midazolam together with droperidol improved table for posteroanterior (PA), lateral, and submental views.
the comfort of the patient during the prodecure.11 The direction of the needle is toward the pupil when one
looks from the front and midpoint of the zygomatic arch
Technique of Needle Insertion
when one looks from the side.
Diagnostic
Block
mucosa (Figure 6-5). There is a definite risk of meningitis
if the needle enters the mucosa. For confirming that the pain generator is the trigeminal
The direction of the needle should be verified under ganglion, after negative aspirations, up to 1 ml of local
fluoroscopy in submental, lateral, and PA views (Figure 6-6). anesthetic (lidocaine, bupivacaine, or ropivacaine) is in-
To obtain the submental view, the C-arm of the jected. The patient should have pain relief if the pain
fluoroscopy is first placed in the PA direction. In this generator is present. The physician should monitor that
view, the orbital line, the petrous ridge may be visualized the solution has not entered the cranial CSF. The brain
through the orbits. The target site in this dimension is a stem function should be evaluated to determine if the lo-
point approximately cal anesthetic solution has not reached it. Brain stem
9 mm to 1 cm medial to the lateral rim of the internal audi- function is affected if the patient complains of bilateral
tory meatus. This usually coincides with the medial extent headache or fourth or sixth nerve palsy, or if pupillary
of a dip that occurs in the petrous ridge. changes occur.
Trigeminal
ganglion
Foramen
ovale
A B
FIGURE 6–4
(A) The drawing shows the needle penetration toward the pupil in the anterior view. (B) This illustration shows the
needle direction 3 cm anterior to the external auditory meatus on the zygoma.
alcohol have been used commonly in the past but are not
recommended currently.
Three neurolytic agents used in neurolysis are alcohol,
phenol, or glycerol.
1. Alcohol is the most spreadable solution and
hence should be used with caution. A maximum
of 1 ml alcohol is used in divided doses watching
for signs of bilateral spread.
2. Phenol is a viscous solution. Consequently, it
will spread less and have more contact time
with the target tissues. The most commonly
used neurolytic agent is 6% phenol in
glycerol. Recently some clinicians are using
6–10% phenol in contrast (Omnipaque)
instead.
3. Glycerol may be directly injected like other neuro-
lytic agents, or the retrogasserian glycerol injection
technique may be used as described below.
Orbit
TECHNIQUE OF TRIGEMINAL GANGLION
STIMULATION AND RADIOFREQUENCY LESIONING
Maxilla Stimulation
Coronoid
process
A test stimulation is mandatory before radiofrequency
Foramen lesioning. Apart from other techniques like glycerol, neu-
ovale rolytic solution injection, or balloon compression, the le-
sion is more precise with radiofrequency lesioning and
should be limited to the affected nerve. Thus, during the
sensorial stimulation the patient should be awake enough
to respond to the test with sensorial stimulation for proper
localization of the tip of the electrode.
Spine The mandibular nerve has some motor fibers. If the
nerve is stimulated at 2 Hz with 0.1 to 1.5 V, the muscle
contraction of the lower mandible is observed. This is also
a way of verifying that the needle is passed through the
FIGURE 6–8 foramen ovale and is on the retrogasserian rootlets. If the
When the submental view is obtained, the foramen ovale is seen to ap- first and second divisions are affected, there should be no
pear medial to the medial edge of the mandible. Depending on the lateral
rotation of the C-arm, the foramen ovale visualization can move more motor response.
medially toward the maxilla. The second step is to seek for paresthesia in the
proper localization. A stimulation at 50 to 100 Hz is given
with 0.1 to 0.5 V. If the needle is properly located, there
will be a tingling-like sensation or electric-like paresthe-
the dye is slower than the CSF itself. The same amount of sias in the innervation of that branch in the face. If this
glycerol is injected in the cistern. The patient is kept at the sensation is obtained after 0.5-V stimulation, then the
same semi-sitting position for the next 2 hours. needle should be redirected to get the same response at a
During this injection, severe headache or dysesthesia lower voltage. However, it should be kept in mind that
may occur, and the patient should be warned about this there might be residual sensorial deficits from previous
result prior to the injection. Some patients may get benefit lesioning.
immediately, whereas some patients may experience relief When the electrode is adjusted for localization, it
within the next 2 weeks. should also be remembered that the gasserian ganglion
Pituitary Anterior
forsa clinoid
Clivus process
A
Petrous part of
Sphenoid
temporal bone Orbit
sinus
External
auditory canal
Foramen
ovale
Base of the skull
Mandible
FIGURE 6–10
FIGURE 6–11
Lateral view radiographic imaging showing the anterior clinoid process
(A), posterior clinoid process (B), clivus (C), temporal bone (D), and line A line drawn perpendicularly (D–E) through where the intersection of
drawn from the point clivus meets the temporal ridge perpendicularly the clivus and petrous part of the temporal bone meet identifies the fora-
towards the base of the skull (D) to (E). At the base of the skull, this locates men ovale at the base of the skull.
the foramen ovale.
Lesioning
Several types of electrodes may be used for lesioning,
such as cordotomy-type electrodes and trigeminal elec-
trodes with the Tew needle and the Racz-Finch curved-
blunt needle. In order to prevent inadvertent puncture of
vessels in the region, it is preferable to use the curved
blunt needle. If the needle is properly placed and stimu-
lated, the patient is then ready for lesioning (Figures 6-13
to 6-16).
Stimulation Parameters
Voltage is 0–1 volts, and sensory, 50 Hz. Paresthesia be-
tween 0.2 and 0.5 V must be noted in the painful zone.
Motor is 2 Hz. Motor contraction of the masseter muscle
FIGURE 6–12
is sought with 0.7–1 V. If no motor contraction happens,
Another lateral view (see Figure 6-10) of the cranium. (A) Clivus.
(B) Petrous part of the temporal bone. (C) Foramen ovale with needle
the tip of the needle is positioned in the I or II branch of
entering it. V cranial nerve.
Lesion Parameters
and its retrogasserian rootlets lie on a plane running from
a superomedial to inferolateral direction. If there is a mo- First lesion: 60 seconds at 65°C. When the lesion is in-
tor response, it means that the needle is too lateral, and for duced, check the bilateral corneal reflex and pain sensitivity
a better response, it should be more medial. in the neuralgic and contralateral zones. Second lesion:
After stimulation is completed, the physician should 60 seconds at 70°C. Proceed in a similar manner. Third
again rule out if the needle is in a vessel or not. If blood is lesion: 60 seconds at 72–75°C. Proceed in a similar manner.
aspirated, the needle position should be adjusted. If blood A fourth lesion may be assessed at 75°C if pain involves
is still aspirated, the procedure should be terminated and two branches of the V cranial nerve.
a second attempt should be made another day. Impedance The patient can either be sedated by midazolam and
monitoring is not essential for trigeminal ganglion lesion- fentanyl or 0.5 ml of 0.25% bupivacaine, or 0.2% ropi-
ing, but if used, it should be 150 to 350 O for rootlets vacaine may be injected. One should wait at least
bathing in the CSF and 1000 O if it is in a non-neural 30 seconds prior to RF lesioning. RF lesioning is done at
tissue. 60°C for 60 seconds. If the patient cannot tolerate the
For the first division lesioning, corneal reflex should be
preserved at each lesion, and lesioning should begin at lesser
degrees than 60°C to preserve the corneal reflex. After the
lesioning is completed, the needle is removed. The patient
is instructed to watch for swelling of the face and to put ice
on the face to reduce any swelling that may occur.
Patient Follow-Up
Immediate and later follow-up of the patient are impor-
tant. Some authors prefer to do the lesioning on an outpa-
tient basis, and some hospitalize the patient for a day. In
some patients there is immediate pain relief, but the next
day or within the first week the pain may return. In such
patients, lesioning may be repeated. The patient should be
monitored for an additional month to determine if side
FIGURE 6–13
effects appear.
Radiofrequency needle entering the facial skin without a catheter. Note
the draping of the patient with the area of entry exposed and an O2 can-
nula in place for trigeminal ganglion radiofrequency.
PERCUTANEOUS TRIGEMINAL GANGLION
BALLOON COMPRESSION
FIGURE 6–14
The alternative technique of introducing the curved-blunt Racz-Finch
radiofrequency needle is shown in this drawing. Initially, an angiocathe-
ter is introduced at the entry site toward the foramen ovale. Following
that, the RF needle is inserted through the angiocatheter.
Coronoid Maxilla
process
Foramen
ovale
Spine
FIGURE 6-16
This drawing of the submental view of the face illustrates the relationship
of the foramen ovale and the needle entry at the medial border of the FIGURE 6-17
mandible and maxilla. The needle entry is shown in the lateral aspect of
The lateral view of the balloon during trigeminal ganglion neurolysis.
the foramen ovale.
sion and highest for RF lesioning. This is not a desirable
Complications condition, but in some patients, because of the intolerable
pain, it may be preferred.12
Significant masseter weakness is a common complication,
especially in the initial period. This weakness generally dis- Motor Deficit
appears within the first 3 months. Hypoesthesia, dysesthesia,
anesthesia dolorosa, balloon failure, and hematoma on the Motor deficit occurs during the lesioning of the third
cheek may also be observed (Table 6-2). branch, the mandibular nerve. The incidence is the high-
est, 66%, with balloon compression. For RF rhizotomy it
is 24%, and for glycerol injection it is 1.7%. The motor
COMPLICATIONS deficit improves within 1 year.
E
F
F
I
C
A
C
Y
B
L
O
C
K
H
I
S
T
O
R
Y
INDICATIONS
FIGURE 6–20
Maxillary nerve block in the lateral view.
Initial needle direction (1) and redirec-
tion (2) after it encounters the pterygoid
Lateral pterygoid plate plate are shown. Inset shows detailed
(anterior margin) 2 anatomy. (From Raj PP, editor:
Practical Management of Pain, 3rd ed.
1 Lateral St. Louis, Mosby, 2000, figure 41-8, p.
pterygoid 586, with permission.)
plate
inward, and upward, making a 40-degree angle the needle is directed upward and backward, and the en-
with the sagittal plane of the skull passing trance to the foramen is felt. The needle should not be in-
tangential to the maxillary tuberosity. When troduced more than 1 cm and only a small amount of
the contact with the bone is lost at a depth of glycerol, 0.2–0.3 ml, may be given to the area. If a larger
3–4 cm from the point of entrance, the needle volume is used, there is the risk of compression
is then advanced 0.5 cm more and 2 ml of neuropathy. Pulsed RF may also be applied.
1% lidocaine is injected.
2. Pterygomaxillary approach: The needle is intro- Complications
duced from the back of the upper molar tooth,
directed upward and inward, almost perpendic- In the extraoral approach, it is essential that the needle
ularly to the tooth. The needle passes laterally be introduced in a horizontal fashion, and it certainly
to the angle formed by the tuberosity of the should not enter the pterygomaxillary fissure in a cephalad
maxilla and the pterygoid process at a depth of direction or advance too deeply, because anesthetic injec-
3.5–4 cm and reaches the sphenomaxillary fossa; tions here are rapidly spread to the posterior aspect of the
2 ml of 1% lidocaine is injected after aspiration orbit and the optic nerve, producing temporary blindness
test. with reversible agents or, more seriously, permanent blind-
3. Posterior palatinal approach: The same technique ness with neurolytic agents. Because of the exceedingly
by the pterygomaxillary route is employed through vascular nature of the compartment in which the maxillary
the posterior palatinal foramen into the canal until nerve lies (the pterygomaxillary fissure is a veritable net-
the needle tip reaches the sphenomaxillary fossa, work of small vessels), intravascular injection is quite
and 2 ml of 1% lidocaine is administered. possible, and meticulous aspiration tests are essential. He-
matoma may develop. If the direction of the needle is too
backwards, penetration to the pharnyx is possible. If this
Infraorbital Block
happens, air can be aspirated in the syringe.
The infraorbital nerve is the terminal branch of the maxil- Toxic reaction to local anesthetics may also develop.
lary nerve. In some cases with trigeminal neuralgia, in Inadvertent puncture of the dura is possible if the
spite of radiofrequency lesioning or other percutaneous needle is advanced too deep. During aspiration CSF may
techniques of the gasserian ganglion, the pain in the area come. In such cases, the block should immediately be
of innervation of the infraorbital nerve continues and in- ceased.
fraorbital block may be useful at that instance. Careful aspiration can help prevent vascular and
The infraorbital foramen is situated 0.5–1 cm below subarachnoid injection. The close proximity of the orbit
the lower margin of the orbit, at the uppermost part of the to this nerve makes it likely to be involved in a complica-
canina fossa. The infraorbital canal is directed 45 degrees tion. Orbital swelling, anesthesia of the orbital tissues,
backward and upward and 20–25 degrees outward and var- ophthalmoplegia, loss of visual acuity, or diplopia can
ies from 1 to 1.5 cm in length. occur if the local anesthetic or neurolytic solution enters
The needle is introduced through a point on the cheek the infraorbital fissure. Damage to vascular structures
0.5–1 cm lateral to the midportion of the ala of the nose. As can cause hemorrhage into the orbit, and blindness can
soon as there is contact with maxilla, below the foramen, occur.
Maxillary nerve
Trigeminal
ganglion
Mandibular
notch
Mandibular
nerve
FIGURE 6–21
A patient with the needle on the maxillary nerve entering through the
mandibular notch.
CLINICAL PEARLS
Trigeminal
ganglion
Mandibular
nerve
Inferior
alveolar
nerve
Lingual
nerve
FIGURE 6–23
The drawing shows the anatomic location of the trigeminal ganglion and
its mandibular and maxillary branches (lateral view).
FIGURE 6–24
This line drawing shows the course of lingual and inferior alveolar
nerve.
pterygoid muscle; and medial to the external pterygoid, the
masseter and the temporal muscles, and the ramus of the
mandible.
Soon after it is formed, the mandibular nerve gives off The terminal branch of the inferior alveolar nerve is
two small branches: the nervus spinosus, which enters the the mental nerve, which exits the mandible via the mental
cranial cavity with the middle meningeal artery to supply foramen and provides sensory innervation to the chin and
the dura, and the nerve to the internal pterygoid muscle. It to the skin and mucous membrane of the lower lip.
then divides into a small anterior and large posterior trunk.
The small anterior trunk, which is composed mostly of INDICATIONS
motor fibers, then promptly divides into the masseteric,
the anterior and posterior deep temporal, and the external The mandibular nerve block is excellent for intraoperative
pterygoid nerves that supply the muscles of mastication or postoperative pain control after surgical reduction of a
and also give off a small sensory branch, the buccinator, fractured mandible. It is also useful for chronic pain states,
which supplies the mucous membrane and skin over this such as carcinoma of the tongue, lower jaw, or floor of the
muscle. The large posterior trunk, on the other hand, is mouth.
composed mostly of sensory fibers. After a short course it
also divides into the auriculotemporal, the lingual, and
inferior alveolar nerves. The auriculotemporal nerve arises CONTRAINDICATIONS
from the posterior aspect of this trunk and immediately
■ Absolute
runs posterolaterally beneath the external pterygoid mus-
■ Local infection
cle to reach the medial side of the neck of the mandible,
■ Coagulopathies
where it turns sharply cephalad to ascend between the
■ Relative
anterior border of the auricle and the condyle of the man-
■ Distorted anatomy
dible under cover of the parotid gland, finally reaching the
subcutaneous tissue overlying the zygomatic arch, where it
divides into the anterior auricular, the external meatal, ar- EQUIPMENT
ticular, parotid, and superficial temporal branches. The
Local Nerve Block
lingual and inferior alveolar nerves proceed in an inferolat-
eral direction to reach the medial side of the ramus of the ■ 22-gauge, 3-1/2-inch spinal needle
mandible and to be distributed to the anterior two thirds ■ 25-gauge, 3/4-inch infiltration needle
of the tongue and inferior jaw, respectively (Figure 6-24). ■ 3-ml syringe
■ 5-ml syringe
■ IV T-piece extension
Pulsed Radiofrequency
■ 10-cm Racz-Finch radiofrequency thermocoagula-
tion needle (RTK)
■ 5-cm RFTC needle may be acceptable
■ 16-gauge, 1-1/4-inch angiocatheter
DRUGS
Local Nerve Block
■ 1.5% lidocaine for skin infiltration FIGURE 6–25
■ 0.5% bupivacaine/ropivacaine The position of the patient and C-arm for an external approach to a
■ 2% lidocaine mandibular nerve block (lateral view).
■ Steroids (optional)
■ Iohexol (Omnipaque 240) contrast medium
Maxillary nerve Trigeminal ganglion
Neurolytics
■ 6% phenol
■ Absolute alcohol
■ 50% glycerol
Mandibular
PREPROCEDURE PREPARATION nerve Mandibular
notch
Physical Examination
Examine for anatomic anomalies and local infections that
may interfere with performance of the block. Also confirm
that the jaw can be opened and closed.
Preoperative Medication
For preoperative medication, use the standard recommen-
dations for conscious sedation by the American Society of
Anesthesiologists.
PROCEDURE
FIGURE 6–26
Position of Patient
Point of needle entry in the mandibular notch for extraoral mandibular
The patient is placed supine on the table. The C-arm is nerve block.
initially placed in an anteroposterior and lateral position to
locate needle entry (Figure 6-25).
of the lower lip, lower jaw, or ipsilateral tongue or ear is
Extraoral Approach obtained (Figure 6-28).
The approach for blocking this nerve is identical to that For best results, paresthesia should be elicited before
for blocking the maxillary nerve, that is, the needle is 2 to 4 ml of anesthetic solution is injected.
introduced through the mandibular notch of the mandi-
ble, and advanced through the infratemporal fossa, with Intraoral Approach
the lateral pterygoid plate serving as a bony endpoint The cheek is retracted by the index finger or retractor
(Figures 6-26, 6-27). However, in this instance, the nee- until the second upper molar tooth is seen. A 5-inch
dle is walked backward off the lateral pterygoid plate, needle is inserted into the mucous reflection above mu-
maintaining the same depth as the plate until paresthesia cosa on the tooth, directed backward, upward, and inward
Maxillary sinus
Needles on:
Mandibular nerve
Maxillary nerve
FIGURE 6–27
Transverse section of the head and face at the level of the mandibular
notch showing needle placement on the mandibular nerve, on the lateral
pterygoid plate, and on the maxillary nerve. After the pterygoid plate is
touched, the needle is slightly withdrawn and pushed posterior until it
slips off the pterygoid plate.
FIGURE 6–28
The technique for the extraoral block of the mandibular nerve is essen-
toward the infratemporal plate. The direction of the tially the same as that for the maxillary block, except that the needle is
needle from lateral view should be toward the midpoint of directed upward and posteriorly; thus, the mandibular nerve is contacted
the zygomatic arch and from the frontal view toward the as it exits from the foramen ovale. (From Raj PP, editor: Textbook of
Re- gional Anesthesia. Philadelphia, Churchill Livingstone, 2002, figure
outer canthus. 20-17, p. 338, with permission.)
At a depth of 4–5 cm, the needle will contact the in-
fratemporal plate, and at that area paresthesia should be
sought. When the patient feels paresthesia, 2 ml of 1% COMPLICATIONS
lidocaine is injected slowly.
Mandibular nerve block, a relatively straightforward
Mental Nerve Block block, is associated with a high degree of success. How-
ever, there is always the risk of complications. As the
In some cases in spite of blocking the gasserian ganglion,
needle is walked posteriorly off the lateral pterygoid
the peripheric branches of the trigeminal nerve are blocked.
plate, it comes to lie on the superior constrictor muscle
The mental nerve is one of them. Also, in some cases with
of the pharynx, which is attached to the border of the
trigeminal neuralgia, only the mental nerve is affected and
lateral pterygoid plate. If the needle is advanced deeper
mental nerve block may be adequate.
at this stage, it can enter the pharynx. If the tip of the
Mental block by extraoral route (by Labat). A line is
needle enters the pharynx, air bubbles will be seen dur-
drawn from the two lower bicuspid teeth perpendicular
ing aspiration.
to the lower margin of the mandible. The distance be-
A very close posterolateral relation of the mandibular
tween the gingival margin of mandible and lower margin
nerve at this site is the middle meningeal artery, which
of the mandible is bisected. Through this bisecting point
enters the cranial cavity through the spinous foramen,
a line is drawn parallel to the lower margin of the man-
thus making meticulous aspiration tests necessary.
dible. These two lines cross each other at right angles and
Hemorrhage in the cheek often occurs during and fol-
their intersection marks the position of the mental fora-
lowing the block by the anterolateral extraoral route. He-
men. The quadrant in which the second bicuspid lies is
matoma of the face and subscleral hematoma of the eye
bisected and a point is taken on the bisector. A 5-cm
may occur.
needle is introduced until it contacts the bone 1.5 cm
from the point of intersection of the lines. The needle is
then inclined slightly inward and passed through the fo- CLINICAL PEARLS
ramen. In some cases the foramen can also be palpated.
The needle should not be introduced too deep in the It should never be necessary to advance the needle more
foramen and the solution should be given in very few than 5.5 cm beyond the skin in the extraoral technique. If
amounts in order to prevent compression over the nerve, paresthesia is not obtained at this depth, the needle should
which may cause neuropathy. Glycerol, 0.2–0.3 ml, may be be withdrawn and the landmarks reconsidered before it is
injected or pulsed. RF may be applied (Figure 6-29). reintroduced.
H mediated by the the parotid gland (Figure
I glossopharyngeal nerve. 6-30A).39
S Intracranial sec- tion of The glossopharyngeal
T the glossopharyngeal nerve exits the jugular
O nerve was first performed fora- men near the vagus
R by Adson in 1925 and and accessory nerves and
Y was subsequently refined the internal jugular vein.40
by Dandy. The All three nerves lie in the
The early use of
intracranial approach to groove between the
Mental nerve glossopharyngeal nerve
section of the internal jugular vein
block in pain management
glossopharyn- geal nerve and internal carotid
centered around two
appeared to yield better artery (Figure 6-30B).
applications: (1) the
M
results for both A significant
treatment of
e glossopharyngeal neuralgia landmark for
glossopharyngeal
n and cancer pain but was a glossopharyngeal nerve
t neuralgia, and (2) the pal-
much riskier procedure.36 block is the styloid
a liation of pain secondary to
l Recently, interest in process of the temporal
head and neck
extracranial de- struction bone. This structure is the
malignancies. In the late
f of the glossopharyngeal calcification of the
1950s, the clinical use of
o nerve by glycerol or by cephalad end of the sty-
r the glossopharyngeal creation of a lohyoid ligament.
a nerve block as an adjunct radiofrequency lesion has Although usually easy to
m to awake endotracheal
e been renewed.37 identify, when ossification
intubation was
n is limited, it may be
documented.
difficult to locate with the
Weisenburg first A
described pain in the exploring needle.
N
distribution of the A
F glossopharyngeal nerve in T I
I
a patient with a cerebello- O N
G
U pontine angle tumor in M D
R 1910.33 In 1921, Harris Y I
E reported the first C
idiopathic case and coined The glossopharyngeal
A
6 nerve is the ninth cranial
–
the term glossopharyn- geal T
2 neuralgia.34 He suggested nerve. It contains both I
9 that blockade of the motor and sensory O
Injection technique for mental glosso- pharyngeal nerve fibers.38 The motor fi- N
nerve block. (From Waldman
might be useful in bers innervate the S
SD: Atlas of Interventional Pain
Management, 2nd ed. palliating this painful stylopharyngeus muscle.
Philadelphia, Saunders, 2003, p. condition. The sensory portion of Indications for
54, with permission.) Early attempts at the nerve innervates the glossopharyngeal nerve
permanent treatment of posterior third of the block are summa- rized in
glossopha- ryngeal tongue, the palatine tonsil, Table 6-3. In addition to
neuralgia and cancer pain and the mucous application for surgical
in the distribution of the membranes of the mouth anesthesia,
E and pharynx. Special glossopharyngeal nerve
F glossopharyngeal nerve
consisted principally of visceral afferent sensory block with local anes-
F
extra- cranial surgical fibers transmit thetics can be used as a
I
section or alcohol information from the taste diagnostic tool when
C
neurolysis of the glosso- buds of the posterior third performing differential
A
pharyngeal nerve.35 These of the tongue. neural blockade in the
C
approaches met with Information from the ca- evaluation of head and
Y
limited success in the rotid sinus and body, facial pain.41
No efficacy studies are treatment of which help control the Glossopharyngeal nerve
available. The efficacy is glossopharyngeal blood pres- sure, pulse, block is used to help
deter- mined by the neuralgia, but were useful and respiration, are differentiate geniculate
patient’s successful pain in some patients suffering carried via the carotid ganglion neuralgia from
relief after the nerve from cancer pain sinus nerve, a branch of glosso- pharyngeal
block. the glossopharyngeal neuralgia. If destruction
nerve.38 of glossopharyngeal nerve
Parasympathetic fibers is being considered, this
GLOSSOPHA pass via the technique is useful as an
glossopharyngeal nerve to indicator of the extent of
RYNGEAL the otic ganglion. motor and sensory
NERVE Postganglionic fibers from impairment that the
BLOCK the ganglion carry patient will likely
secretory information to experience.42
Glossopharyngeal nerve
block with local anesthetic
may be used to palliate
acute pain emergencies,
including glossopharyngeal
neu- ralgia and cancer
pain until pharmacologic,
surgical, and
Glossopharyngeal nerve
Internal
jugular vein
Vagus nerve
Internal
carotial artery
A B
FIGURE 6–30
(A) The anatomy of the glossopharyngeal nerve as it exits the jugular foramen. Note the close relationship of the vagus nerve. (B) This
is an anatomical dissection of the region where the glossopharyngeal nerve is traversing below the jugular foramen close to vagus, acces-
sory nerves and internal carotid artery, and internal jugular vein. (Courtesy of U. Pai, MD.)
antiblastic methods take indications are EQUIPMENT A
effect.43 This technique compelling, blockade of d
Local Nerve Block j
is also useful for atypical the glossopharyngeal
u
facial pain in the nerve using a 25-gauge ■ 25-gauge, 3/4-inch n
distribution of the needle may be carried out needle for infiltration c
glossopharyngeal nerve44 in the presence of ■ 22-gauge, 1- t
and as an adjunct for coagulopathy, al- beit 1/2-inch needle
awake en- dotracheal with increased risk of for injection at t
intubation.45 ecchymosis and the site o
Destruction of the hematoma formation. ■ 3-ml syringe
glossopharyngeal nerve ■ IV T-piece a
is indi- cated in the extension w
palliation of cancer pain, a
k
including invasive tumors Pulsed Radiofrequency e
of the posterior tongue,
hypopharynx, and ton- ■ 16-gauge, 1-1/4-
inch catheter i
sils.38 This technique is n
■ 5-cm
useful in the management t
radiofrequency
of the pain of u
thermocoagulation
glossopharyngeal b
neuralgia for those (RFTC) needle a
patients who have failed with 5-mm active- t
to respond to medical tip Racz-Finch i
Kit Needle o
management or who are n
not candidates for surgical Neurolytic Block or
microvascular de- Neurodestructive Procedure
compression.46 Cancer pain (palliation)
TABLE 6–3 Indications for
Management of glossopharyngeal
Glossopharyngeal Nerve neuralgia
C Block
O Local Anesthetic Block
N Surgical anesthesia
T Differential neural blockade
R Prognostic nerve block prior to
A neurodestructive procedures
I A
N c
u
D
t
I e
C
A
p
T a
I i
O n
N
S e
m
Contraindications to the e
blockade of the r
glossopharyngeal nerve g
are summarized in Table e
n
6-4. Local infection and
c
sepsis are absolute i
contraindications to all e
procedures. Coagulopathy s
is a strong
contraindication to (
glossopha- ryngeal nerve p
block, but owing to the a
desperate nature of many l
l
patients’ suffering from i
invasive head and face a
ma- lignancies, ethical and t
humanitarian i
considerations dictate its o
n
use, despite the risk of
)
bleeding.
When clinical
TABLE 6-4 Contraindications i D For preoperative
to Glossopharyngeal Nerve c U medication, use the
Block a
l
R standard recommen-
L
E dations for conscious
o a sedation by the American
c n P Society of
a o R Anesthesiologists.
l m
a
E
l P
i y A P
n R R
f A
e O
T C
c
D I E
t
i
R O D
o U N U
n G R
S P
h E
S y
L P
e
o s
p o
c i
s s
a c
i i
l a
s t
l
i
N o
C E
e n
o x
r
a a
v o
g m
e f
u i
l
B n
o P
l a
p a
o t
a t
c i
t i
k o
h e
n
y n
■ 1.5% lidocaine for
S It is customary to obtain a t
i skin infiltration
full history and physical
g ■ 0.5%
n exami- nation. The a
ropivacaine/bupivacai
i
ne mixture physical examination n
fi should include an assess- d
c ■ 2% lidocaine
a ■ Steroids (optional)
ment of the ability to
n move the neck and P
■ Iohexol
t inspection for normal h
(Omnipaque 240) y
landmarks at the site of
b s
the needle insertion. i
e N
h e c
a u P i
v r a
i r
o e n
o
l o
r The patient is placed in
a y p
s the supine position. The
l e
i r land- marks are (1)
a s a ipsilateral mastoid
b t process; (2) angle of the
■ 6% phenol in
n i mandible, anteriorly; and
o glycerin/iohexol v (3) feel the styloid process
r ■ Absolute alcohol e
m of the temporal bone, in
(97%)
a the middle between the
l M two landmarks. An
i e
t imaginary line is
P d
i i visualized or drawn
R
e
c running from the mastoid
s E
a process to the angle of the
A P
n R
t mandible.47 The fluo-
a i roscope should be placed
O o
t in an oblique position
o C n
m E and di- rected toward the
area of the mandible and at this midpoint location fluoroscopic image was Impedance was
the mastoid process in a plane perpendicular obtained. The styloid approximately 220 ohms
(Figure 6-31). The styloid to the skin. The styloid process, mastoid, and but dropped to
process should lie just process should be angle of the mandibular 113–140 ohms following
below the midpoint of this encountered within ra- mus were visible. An instillation of 3 cc of a
line. 3 cm. After contact is intracutaneous skin wheal 1:1:1 mixture of lidocaine
made, the needle is with 1% lidocaine was 2%, ropivacaine 0.2%, and
E withdrawn and walked raised at a point 4 mg dexamethasone.
x off the styloid process overlying the distal tip of Pulsed radiofrequency
t posteriorly. As soon as the styloid process. A 16- lesioning was per- formed
r bony contact is lost and gauge angiocatheter was for three cycles of 120
a placed about 1.5 cm seconds at a constant tem-
careful aspiration reveals
o
no blood or CSF, 7 ml of through the skin, aiming perature of 42°C. The
r
a 0.5% preservative-free for the styloid pro- cess. rate was 2 Hz, and the
l lidocaine combined with An anteroposterior view pulse width was 20
80 mg of confirmed that the tip of milliseconds. The
A methylprednisolone is the needle was at the patient was monitored
p injected in incremental level of the mandibular for
p doses. ramus. A 1 hour postprocedure,
r 20-gauge blunt curved andvital signs
Subsequently, daily
o radiofrequency needle remained stable.
a nerve blocks are
c performed in the same (RFK),
h manner, but 40 mg of 10 cm in length, 10-mm
methylprednisolone are active tip is advanced
The skin is prepared through the angiocatheter
substituted for the first
with antiseptic solution. until bony contact with
80-mg dose. This
After a local infiltration the styloid process is
approach may also be used
with a 25-gauge needle, made. The needle is then
for breakthrough pain in
a 22-gauge, walked off posteriorly
patients who previ- ously
1.5-inch needle attached experienced adequate pain and advanced another 1–
to a 3–5-ml syringe is 1.5 cm (Figure 6-34).
control with oral medica-
advanced Intermittent dual rotation
tions (Figures 6-32 and 6-
33).46 C-arm fluoroscopy was
used during needle
advancement. Aspiration
P with a 1-cc syringe was
u
l
negative for blood and
s CSF. One to 2 milliliters
e of Omnipaque
d 240 mg/dl, iodinated,
nonionic contrast
R demonstrated lo- cal
a filling, inferior spread,
d and absence of vascular
i
runoff on a lateral view
o
f (Figure 6-34). A line
r drawing of this
e fluoroscopic projection is
q displayed (Figure 6-35).
u Sen- sory stimulation up
e
to 1 volt at 50 Hz
n
c reproduced concor- dant
y pain at the base of the
tongue, pharynx, and
Informed consent and tonsils. Motor stimulation
intravenous access were up to 2.5 volts at 2 Hz
obtained. The patient reproduced lo- cal
was placed supine on the muscular contractions.
fluoroscopy table. Oxygen Contractions of the
was administered by nasal muscles innervated by
cannula, and vital signs the phrenic and spinal
were monitored accessory nerves were
noninvasively. The right absent. The patient
mastoid, lateral neck, and remained
mandible were prepped hemodynamically stable
and draped in a sterile without any bradycardic
fashion. A lateral or hypotensive episodes.
FIGURE 6–33
The lateral radiographic view shows the tip of the needle on the styloid
process (arrow). This position ensures that the needle tip is close to the
FIGURE 6–31 glossopharyngeal nerve.
The C-arm is turned obliquely toward the mandible to visualize the sty-
loid process to create a lateral radiographic image.
Trigeminal
Styloid process
ganglion
Vagus n.
Mandibular n. Jugular
foramen 2
Lingual n.
1
FIGURE 6–35
Inferior Drawing detailing relevant anatomic
alveolar n. structures, initial needle position con-
Styloid process
tacting styloid process (1), and final
Glossopharyngeal n. position at glossopharyngeal nerve (2).
2 (Adapted from Shah RV, Racz GB:
Case conference: pulsed mode radio-
Stylohyoid frequency lesioning to treat chronic
ligament post-tonsillectomy pain. Pain
Pract
Internal 3:233, 2003, with permission.)
jugular v. 1
External
carotid a.
Internal carotid a.
Glossopharyngeal
nerve
for the clinical effect of O to vagal nerve block is block results in
RF.66 Pulsed RF may M also observed in some weakness of the tongue
provide long-term pain P patients.38 Inadvertent and trapezius muscle. 68
relief, reduce analgesic L block of the hypoglossal A small percentage of
consumption, and provide I and spi- nal accessory patients who undergo
patient satisfaction.66 C nerves during chemical neurolysis or
Even when the pain A glossopharyngeal nerve neurodestructive
recurs, the procedure is T procedures of the glosso-
easily repeatable. I pharyngeal nerve
Technically, there are O experience postprocedure
several percutaneous N dysesthesias in the area of
S the nerve.69 These
methods to target the
glossopharyngeal nerve. Inadvertent puncture of symptoms range from a
An intraoral approach is either vessel during mildly uncomfortable
often used for preemptive glossopha- ryngeal nerve burning or pulling
analgesia,67 but this block can result in sensation to severe pain.
method caries the risk of intravascular injection or Such severe
infection and iatrogenic hematoma formation. postprocedure pain is
injury to several Even small amounts of called anes- thesia dolorosa.
neurovascular structures, local anesthetic injected Anesthesia dolorosa can
including internal carotid into the carotid artery at be worse than the
artery, vagus nerve, this site can produce patient’s original pain and
brainstem, vertebral artery, profound local anesthetic is often harder to treat.
and upper cervical spinal Slough- ing of skin and
toxicity.36
nerves. Two extraoral subcutaneous tissue has
Because extraoral
approaches can be been associated with
blocks of the
performed with anesthesia dolorosa.
glossopharyngeal nerve
fluoroscopic guidance. The glossopharyngeal
can readily spread to
One approach, similar to nerve is susceptible to
the vagus and accessory
that used for trigeminal trauma from needle,
nerves, neurolytic blocks
ganglion blockade, uses hematoma, or
often produce analgesia
Hartel’s pro- jection.58 compression during
of the hemilarynx and/or
Instead of aiming for the injection procedures. Such
trapezius muscle, and
foramen ovale, the op- complications, although
sternocleido- mastoid
erator aims for the usually transi- tory, can be
paralysis on the ipsilateral
medial part of the jugular quite upsetting for the
side. Both these com-
foramen. This approach, patient.
plications may be well
however, can cause severe Even though risk of
tolerated by patients with
damage to the vital infection is uncommon, it
terminal cancer pain.
neurovascular structures is ever present, especially
The major
mentioned earlier. The in patients with cancer
complications associated
tech- nique of Shah and who are
with glossopha- ryngeal
Racz can be safely immunocompromised.44
nerve block are related to
performed, especially Early detection of
trauma to the internal
when curved blunt infection is crucial to
jugular vein and carotid
needles, contrast avoid potentially life-
artery.38 Hematoma
fluoroscopy, prepro- threatening sequelae.
formation and
cedure motor and sensory intravascular injection of
electrical stimulation, local anesthetic with sub- C
hemody- namic sequent toxicity are L
monitoring, and pulsed significant problems for I
mode RF are used. These the patient. Blockade of N
technical refinements may the motor portion of the I
dispel concerns about this glossopharyngeal nerve C
pro- cedure’s safety and can result in dysphagia A
permit its gradual re- secondary to weakness of L
introduction as a the stylopharyngeus
treatment for muscle.43 If the vagus P
glossopharyngeal nerve is inad- vertently E
neuralgia. Larger studies blocked, as it often is A
are needed to further during glossopharyngeal R
substantiate claims of nerve block, dysphonia L
safety and efficacy. secondary to paralysis of S
the ip- silateral vocal
cord may occur. Reflex Patients with pharyngeal
tachycardia sec- ondary cancer will often have
C
undergone radical neck
dissection and the
sternocleidomastoid The term occipital
muscle will have been neuralgia was first used in
removed. This makes 1821, when Beruta y
identification of the Lentijo and Ramos made
styloid process much reference to an oc-
easier, since this particular cipital neuralgic
bony landmark is now syndrome.70 The
almost subcutaneous, technique of occipital
allowing this block to be
performed easily.
Because of the
proximity of the large
vascular conduits of the
internal carotid artery and
the internal jugular vein,
the risks of intravascular
injection are always
significant, demanding
meticulous aspiration tests.
With the temporary and
perhaps permanent
analgesia produced by this
block, a degree of
incoordination of
swallowing, with the
accompa- nying potential
risk of aspiration, must be
appreciate d by patients
and attendants alike. With
numbness of half of the
pharynx and the larynx,
ingestion and swallowing
are often severely
compromised.
E
F
F
I
C
A
C
Y
GREATER AND
LESSER
OCCIPITAL
NERVE
BLOCKS
H
I
S
T
O
R
Y
nerve block seems to be first described by Bonica in
1953.71
ANATOMY
The greater occipital nerve gets fibers from the dorsal
primary ramus of the second cervical nerve and to a lesser Greater
extent from the third cervical nerve. The lesser occipital occipital nerve
nerve arises from the ventral primary rami of the second
Lesser
and third cervical nerves (Figure 6-36). occipital
The greater occipital nerve ascends in the posterior nerve
neck over the dorsal surface of the rectus capitis posterior
major muscle, at the midpoint of this muscle; turns dor-
sally to pierce the semispinalis capitis; and then runs a Sternocleidomastoid
short distance rostrolaterally, lying deep to the trapezius. muscle
The nerve becomes superficial below the superior nuchal
line, along with the occipital artery.
It supplies the medial portion of the posterior scalp
as far anterior as the vertex. The lesser occipital nerve
passes superiorly along the posterior border of the sterno-
cleidomastoid muscle, innervating the lateral portion of FIGURE 6–36
the posterior scalp and the cranial surface of the pinna of Anatomy and technique of injection of the greater occipital nerve.
(A) The third occipital nerve, which is not shown, is usually located me-
the ear.72–74 dial to the greater occipital nerve. The lesser occipital nerve (B) can be
blocked at a point 2.5 cm lateral to the site of the injection for greater
occipital nerve block.
INDICATIONS
Neurolytic Block
The needle is advanced until a paresthesia is encoun-
tered. It will be better to seek for paresthesia with a FIGURE 6–37
stimulator. When the paresthesia is met, 1 ml 6% phenol Anatomic landmarks for skin entry points of the greater occipital nerve
(A) and lesser occipital nerve (B).
in glycerine or Omnipaque is slowly injected after nega-
tive aspiration.
CLINICAL PEARLS
Pulsed Radiofrequency The principal role of occipital nerve block is for the diag-
nosis of occipital neuralgia. If a diagnostic block is planned,
A 5-cm radiofrequency needle with 5-mm active tip is the dose should be limited to 1–2 ml to minimize confusion
advanced to make contact, through a previously intro-
duced catheter, with the bone in the close vicinity of the
Lesser occipital nerve
nerve. Sensorial stimulation with a frequency of 50 Hz is
the next step. The stimulation should be felt below
0.5 V. When the patient feels the paresthesia, 1 ml of
2% lidocaine is injected. Ten minutes later, pulsed RF
at
42°C for two or three cycles of 120 seconds is performed
(Figure 6-38).
COMPLICATIONS
A
N
A
T
O
M
Y
Mo
ng
bac
ward
s
loos
ens
infe
or
obliq
ue
mus
cle;
grea
ter
occi
pital
ner
e
ent
apm
ent
less
ens
F
I
G
U
R
E
6
–
aspect of the inferior nuchal line of the occiput. It rotates
the skull ipsilaterally.
The obliquus capitus superior muscle is the lateral,
upper border. It originates from the transverse process of
the atlas and inserts on the occipital bone between the
superior and inferior nuchal lines lateral to the semispina-
Forward movement
lis capitus. The obliquus capitus superior pulls the head
tightens inferior backward to the ipsilateral side.
oblique muscle - The obliquus capitus inferior is the lateral boundary
more entrapment of
greater occipital nerve
below, and it originates from the spinous process of the
axis and inserts on the transverse process of the atlas. It
rotates the atlas and occiput. The roof of the space is a
FIGURE 6–40
tough layer of connective tissue beneath the semispinalis
Forward movement tightens inferior oblique muscle. More entrapment
of greater occipital nerve. capitus, and the floor is the occipito-atlantal membrane
and posterior arch of the atlas.
The posterior branch of the first occipital nerve, the
suboccipital nerve, exits posteriorly between the occiput
and the posterior arch of the atlas. It supplies
the muscles bounding the suboccipital triangle and com-
municates with the greater and lesser occipital nerves.
Entrapment can occur at the obliquus capitus inferior
(inferior oblique) or semi-spinalis or trapezius (Figures
6-43 and 6-44).
FIGURE 6–43
Lateral view suboccipital entrapment.
Semispinalis
muscle
(entrapment)
Inferior
oblique muscle
(entrapment)
FIGURE 6–42
Methylene blue injected bilaterally shows suboccipital compartment FIGURE 6–44
spread on right. Occipital nerves are retracted. Posterior view suboccipital entrapment.
I ■ 0.2% ropivacaine – The suboccipital
4
N 5 compartment opens and
D S injectate spreads in the
I T t perineural space of greater
C E e occipital nerve (Figures 6-
A a
C l 46 and 6-47).
T H t
I N h
O I
N Q n
S U e
e
E d
■ Diagnostic
l
therapeutic The patient is positioned e
■ Suboccipital in the prone position
tenderness with the neck in flexion. p
dorsolateral C1-C2 The nuchal line is l
area a
palpated. Skin entry is c
■ Occipital frontal made 1/2 inch e
headache paramedial. Aim and m
e
advance the stealth needle n
through fascial layers t
C
(Figure 6-45). .
O
On the lateral
N
T fluoroscopic view, the
R direction should be
A toward the arch of C1.
I Inject contrast, which
N should spread around
D needle tip and not within
I the nerve. Ten milliliters
C of 0.2% ropivacaine and
A 20 mg of depomedrol are FIGURE 6–46
T used for the block. Anteroposterior view with
I contrast.
O
N
S
■ Infection
■ Previous local
surgery unless Injected
contrast is used volume opens
up the
ent
compa
E filling
Q
U The three
entrapme
I
nts
P 1)
M Trapezius
E 2)
Semispin
N alis
T (cont
and
■ Stealth needle anesthetic
)
■ Fluoroscopy 3) In
■ Small-bore tubing oblique
■ Syringe
D FIGURE 6–47
R F Lateral view with contrast.
I
U G
G U
S R
E
■ Corticosteroid
■ Omnipaque 240 6
C Memorrio et bulletin de médicine decompression for the 17. Burchiel K: Percutaneous
et chirurgie de surgical management of tic retrogasserian glycerol
O douloureux. Neurosurgery
Bordeaux. 1902, 91–96. rhizolysis in the
M 2. Swerdlow M: The history 9:111–119, management of trigeminal
P of neurolytic block. In Racz 1981. neuralgia. J Neurosurg
L GB, editor: 15. Fraoili B, Esposito V, 69:361–366, 1988.
I Techniques of Neurolysis. Guidetti B, et al: 18. Wilkinson H: Trigeminal
Boston, Kluwer Academic Treatment of trigeminal nerve peripheral branch
C Publishers, 1989. neuralgia by phenol/glycerol injections
A 3. Cushing H: The role of thermocoagulation, for tic douloureux. J
T deep alcohol injections in glycerolization, and Neurosurg 90:828–832, 1999.
I the treatments of trigeminal percutaneous compression 19. North RB, Kidd DH,
neuralgia. JAMA 75:441– of gasserian ganglion and/or Piantadosi S, Carson BS:
O
443, 1920. retrogasserian rootlets: Percutaneous ret-
N 4. Hartel F: Die long-term results and rogasserian glycerol
S Leitungsanesthesie und therapeutic protocol. rhizotomy: predictors of
Injektionsbehandlung des Neurosurgery 24:239– success and failure in
All complications have Ganglion Gasseri und der 245, 1989. treatment of trigeminal
Trigeminusaeste. Arch Klin 16. Fujimaki T, Fukushima T,
followed the use of a neuralgia. J Neurosurg
Chir 100:193– Miyazaki S: Percutaneous 72:851–856, 1990.
sharp needle and 292, 1912. retrogasserian glycerol 20. Sweet WH, Poletti CE,
intraneural injection 5. Kirschner M: Zur injection in the Macon JB: Treatment of
leading to respiratory Electrochirurgie. Arch Klin Chir management of trigeminal trigeminal neu- ralgia and
161:761–768, 1931. neuralgia: long- term
arrest and brain stem 6. Putnam TJ, Hamptom
other facial pains by
follow-up results. J retrogasserian injection of
infarction in settings AO: The technic of Neurosurg 73:212–216, 1990. glycerol. Neurosurgery
where the occurrence of injection into the 9:647–654, 1981.
these problems is not Gasserian ganglion under 21. Lobato RD, Rivas JJ,
roentgenographic control. Rosario S, Lamas E:
appreciated such as the Arch Neurol Psychiatry Percutaneous microcom-
office set- ting where the 35:92–98, 1936. pression of the gasserian
personnel are not trained 7. Sweet WH, Wepsic JG: ganglion for trigeminal
or ready to ad- minister Controlled neuralgia. J Neurosurg
thermocoagulation of 7
airway support and trigeminal ganglion and 2
ventilation. However, rootlets for differential :
these complications are destruction of pain fibers. I. 5
extremely rare and Tri- geminal neuralgia. J 4
Neurosurg 40:43, 1974. 6
preventable. 8. Hakanson S: Trigeminal –
neuralgia treated by the 5
injection of glycerol into the 5
E trigeminal cistern. 3
F Neurosurgery 9:638–646, ,
1981.
F 9. Mullan S, Lichtor T:
I 1
Percutaneous 9
C microcompression of the 9
A trigem- inal ganglion for 0
C trigeminal neuralgia. J .
Neurosurg 59:1007–1012, 22. Belber CJ, Rak RA:
Y 1983. Balloon compression
10. Warwick R, Williams PL, rhizolysis in the surgi- cal
Reports of successful editors: Gray’s Anatomy, British management of trigeminal
treatment with single ed. 35. neuralgia. Neurosurgery
injections have been Edinburgh, Churchill 20:908–913,
Livingstone, 1973.
described.77,78 A 11. Brisman R: Analgesia and
1
9
randomized controlled sedation during 8
trial of injec- tions of percutaneous radiofre- 7
local anesthetic with and quency electrocoagulation .
for trigeminal neuralgia. 23. Brown JA, McDaniel M,
without corticosteroid Neurosurgery Weaver MT: Percutaneous
showed superior benefit of 32,400–405, 1993. trigeminal nerve
steroids in patients with 12. Taha JM, Tew JM: compression for treatment
cluster headache.79 Comparison of surgical of trigeminal neuralgia:
treatments for trigeminal results in
neuralgia: reevaluation of 50
radiofrequency rhizotomy. pati
Neurosurgery ents
R 38:865–871, 1966. .
E 13. Broggi G, Franzini A, Lasio Neu
G, et al: Long-term results rosu
F of percu- taneous rger
E retrogasserian y
R thermorhizotomy for 32:5
E “essential” trigeminal 70–
neuralgia. Neurosurgery 573,
N 199
26:783–787, 1990.
C 14. Burchiel K, Steege T, Howe 3.
E J, Loeser J: Comparison of 24. Sweet WH: Complications
S percutane- ous of treating trigeminal
radiofrequency gangliolysis neuralgia: an analysis of the
1. Pitres JA, Verger TPH: and microvascular literature and response to
questionnaire. In Rovit RL, ed. 7
Murali R, Jannetta PJ, St. .
editors: Trigeminal Lou 37. Shah RV, Racz GB: Case
Neuralgia. Baltimore, is, conference—pulsed mode
Williams & Wilkins, 1990, Wa radiofrequency lesioning to
pp. 251–279. rren treat chronic post-
25. Sekhar LN, Heros RG, H. tonsillectomy pain
Kerber CW: Carotid- Gre (secondary glos-
cavernous fistula fol- lowing en sopharyngeal neuralgia).
retrogasserian procedures. J Inc., Pain Pract 3:232–237, 2003.
Neurosurg 51:700–706, 1979. 198 38. Bonica JJ: Neurolytic
26. Rish BL: Cerebrovascular 5. blockade and
accident after 33. Weisenburg TH: hypophysectomy. In Bonica
percutaneous radiofre- Cerebellopontine tumour JJ, editor: The Management
quency thermocoagulation diagnosed for six years as tic of Pain, 2nd ed. Philadelphia,
of the trigeminal ganglion. douloureux. JAMA 54:1600– Lea & Febiger,
J Neurosurg 1604, 1910. 1
4 34. Harris W: Persistent pain 9
4 in lesions of the peripheral 9
: and central nervous system. 0
3 Brain 44:557–571, 1921. ,
7 35. Doyle JB: A study of four
6 cases of glossopharyngeal
neuralgia. Arch p
– p
3 N
e .
7
7 u
, r 1
o 9
l 9
1 6
9 –
7 P
s 1
6 9
. y
c 9
27. Sweet WH, Poletti CE, 9
Roberts JT: Dangerous rises h
i .
in blood pres- sure upon 39. Pitkin GP: The
heating of trigeminal a
t glossopharyngeal nerve.
rootlets: increased bleeding In Southworth JL,
r
time in patients with Hingson RA, editors:
y
trigeminal neuralgia. Conduction Anesthesia.
Neurosurgery 17:843–844, Philadelphia, JB Lippin-
1 9 cott, 1946, pp. 46–49.
9 :
40. Bajaj P, Gemavat M, Singh
8 3
DP: Ninth cranial nerve
5 4
block in the management of
. –
3 malignant pain in its
28. Apfelbaum, RI: Comparison
6 territory. Pain Clin 6:153–
of the long-term results of
, 208,
microvascular decompression
1
and percutaneous trigeminal 9
neurolysis for the treat- ment 1 9
of trigeminal neuralgia. 9 3
International Congress 2 .
Series, Volume 3 41. Romanoff M: Somatic nerve
1247, December 2002, pp. . blocks of the head and neck.
629–643. Developments in 36. Dandy WE: In: Raj PP, editor: Practical
Neuroscience. Proceedings Glossopharyngeal neuralgia: its Management of Pain, 3rd ed.
of the 2nd International diagnosis and treatment. St. Louis, Mosby Inc.,
Mt. Bandai Symposium for A 2
Neuroscience 2001, Bandai, r 0
Japan, October 27, 2001. c 0
29. Allen CW: Local and Regional h 0
Anesthesia. Philadelphia, WB ,
Saunders, S
1 u
9 p
r p
1 g
5 .
.
30. Schlosser H: Erfahrungen in 1 5
der Neuralgiebehandlung 5 7
mit Alkohol- : 9
1 –
einspritzungen: Verhandl. D
9 5
Cong Finnere Med 24:49,
8 9
1907.
– 6
31. Levy F, Baudoin A: Les
2 .
injections profondes dans le 1
traitment de la neuralgie. 42. Pai TP, Nayak R, Molloy R:
5
Presse Med 13:108, 1906. Head and neck blocks. In:
,
32. Adriani J: Labat’s Regional Benzon HT, Raja SN,
Anesthesia: Techniques and Clinical Molloy RE, et al, editors.
Applications, 1 Essentials of Pain Medicine
4 9 and
2